team grant: european rare diseases research alliance (erdera) joint transnational call 2025

cihr-ig is pleased to be partnering with approximately 34 international funding organizations in the context of this european rare diseases research alliance (erdera) joint transnational call (jtc) 2025. cihr-ig is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across canada and the european community (ec) to collaborate for better health outcome for the rare disease patient community.

the topic of the call is pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.

projects should focus on a group of rare diseases or on a single rare disease if there is no valid rationale/evidence for the benefit of grouping diseases. if focusing on a single rare disease, applicants must clearly specify why working on a group of rare diseases is not appropriate. the classification of rare diseases follows the european definition, i.e. a disease affecting not more than five in 10,000 persons in the european community, ec associated states, and canada.